New insights into NAFLD and subclinical coronary atherosclerosis
- PMID: 29410378
- PMCID: PMC5903205
- DOI: 10.1016/j.jhep.2018.01.023
New insights into NAFLD and subclinical coronary atherosclerosis
Conflict of interest statement
Comment on
-
Association between non-alcoholic fatty liver disease and subclinical coronary atherosclerosis: An observational cohort study.J Hepatol. 2018 May;68(5):1018-1024. doi: 10.1016/j.jhep.2017.12.012. Epub 2017 Dec 20. J Hepatol. 2018. PMID: 29274406
References
-
- Stepanova M, Younossi ZM. Independent association between nonalcoholic fatty liver disease and cardiovascular disease in the US population. Clin Gastroenterol Hepatol. 2012;10:646–650. - PubMed
-
- Targher G, Byrne CD, Lonardo A, Zoppini G, Barbui C. Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis. J Hepatol. 2016;65:589–600. - PubMed
-
- Ekstedt M, Hagstrom H, Nasr P, Fredrikson M, Stal P, Kechagias S, et al. Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up. Hepatology. 2014 - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical